⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0002051419

Schultes Birgit C

Reports to the SEC for 1 company · CAMBRIDGE, MA

Transactions

6

Companies

1

Filings

4

CIK

0002051419

Forms 4 and 5

Insider transactions

6 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-01	NTLAIntellia Therapeutics, Inc.A Award	EVP, Chief Scientific Officer	AAward	+39.2K sh	—	—	137,733
2026-03-01	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	EVP, Chief Scientific Officer	AAward	+56K sh	—	—	56,000
2026-01-05	NTLAIntellia Therapeutics, Inc.S Sale	EVP, Chief Scientific Officer	SSale	−8,508 sh	$9.21	−$78.4K	98,533
2025-10-01	NTLAIntellia Therapeutics, Inc.S Sale	EVP, Chief Scientific Officer	SSale	−31 sh	$17.38	−$538.78	105,184
2025-03-01	NTLAIntellia Therapeutics, Inc.A Award	EVP, Chief Scientific Officer	AAward	+37.6K sh	—	—	105,215
2025-03-01	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	EVP, Chief Scientific Officer	AAward	+53.7K sh	—	—	53,714

Recent filings

4

Accepted (ET)
Mar 34
Schultes Birgit C0001193125-26-088251
SEC(opens sec.gov)
Jan 74
Schultes Birgit C0001193125-26-006292
SEC(opens sec.gov)
Oct 34
Schultes Birgit C0001193125-25-230424
SEC(opens sec.gov)
Mar 44
Schultes Birgit C0000950170-25-032101
SEC(opens sec.gov)

Companies

1

Intellia Therapeutics, Inc.EVP, Chief Scientific OfficerNTLA

Address

C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET, SUITE 130

CAMBRIDGE, MA, 02139